Gunther Birznieks, SVP, Business Development at Vanda Pharmaceuticals Inc. (VNDA), sold 33,554 shares at $6.20 ($209K) on 2023-03-02, disclosed to the SEC on 2023-03-06.
Seasonal sale ($209k) by SVP, Business Development — this insider has traded VNDA in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.20 | 8,509 | $53K | 25.2% |
| 2 | $6.20 | 8,509 | $53K | 25.2% |
| 3 | $6.26 | 8,268 | $52K | 24.8% |
| 4 | $6.26 | 8,268 | $52K | 24.8% |
| Total | $6.23 avg | 33,554 | $209K | 100% |
| Filing → |
| VNDA | SELL | 2022-03-02 | $305K | — | Filing → |
| VNDA | SELL | 2021-03-03 | $748K | — | Filing → |
| VNDA | SELL | 2020-03-04 | $363K | — | Filing → |